Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.55 - $6.41 $2,275 - $3,205
-500 Reduced 17.24%
2,400 $11,000
Q4 2021

Feb 14, 2022

BUY
$5.89 - $9.73 $2,945 - $4,865
500 Added 20.83%
2,900 $17,000
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $6,780 - $9,890
1,000 Added 71.43%
2,400 $20,000
Q2 2021

Aug 10, 2021

SELL
$7.24 - $11.2 $7,240 - $11,200
-1,000 Reduced 41.67%
1,400 $11,000
Q1 2021

May 11, 2021

BUY
$8.05 - $20.78 $3,220 - $8,312
400 Added 20.0%
2,400 $25,000
Q4 2020

Feb 12, 2021

BUY
$2.36 - $9.99 $4,720 - $19,980
2,000 New
2,000 $17,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $204M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.